Literature DB >> 8336522

A novel subtype of endothelin B receptor mediating contraction in swine pulmonary vein.

S A Sudjarwo1, M Hori, M Takai, Y Urade, T Okada, H Karaki.   

Abstract

Effects of agonists and antagonists of endothelin (ET) receptors were examined in swine pulmonary artery and vein and in rabbit saphenous vein. ET-1, but not ETB receptor agonists, sarafotoxin S6c (STXc) and IRL 1620, induced contraction in pulmonary artery. This effect was inhibited by the ETA receptor antagonists, BQ-123 and FR139317, but not by the ETB receptor antagonist, IRL 1038. Pulmonary artery precontracted by norepinephrine was relaxed by ET-3 in an endothelium-dependent manner. This relaxation was inhibited by IRL 1038 but not by BQ-123. In pulmonary vein, ET-1, ET-3, STXc and IRL 1620 induced contractions at a similar concentration range. ET-1 induced contraction also in saphenous vein. These contractions were not inhibited by BQ-123, FR139317 or IRL 1038. These results suggest that the isopeptide-selective ETA receptor mediates contraction in swine pulmonary artery whereas the isopeptide-nonselective ETB receptor mediates release of endothelium-derived relaxing factor. In contrast, contractions in the veins may be mediated by a novel subtype of isopeptide-nonselective ETB receptor which is not inhibited by IRL 1038.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8336522     DOI: 10.1016/0024-3205(93)90647-l

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Structural basis of the function of endothelin receptor.

Authors:  T Masaki; H Ninomiya; A Sakamoto; Y Okamoto
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.

Authors:  D W Hay; M A Luttmann; G Beck; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

3.  Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

Authors:  Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

4.  Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Mostafa M Elgebaly; Alex K Harris; Jim R Hutchinson; Erin M Mezzetti; Vera Portik-Dobos; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

5.  Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.

Authors:  Patrik Rossi; Björn Persson; Piet J M Boels; Anders Arner; Eddie Weitzberg; Anders Oldner
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

6.  A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells.

Authors:  N Kitagawa; K Tsutsumi; M Niwa; S Yamaga; T Anda; H Khalid; A Himeno; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1994-04       Impact factor: 5.046

7.  Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.

Authors:  T Watanabe; Y Awane; S Ikeda; S Fujiwara; K Kubo; T Kikuchi; K Kusumoto; M Wakimasu; M Fujino
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  Endothelin receptors mediating functional responses in human small arteries and veins.

Authors:  J Riezebos; I S Watts; P J Vallance
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

9.  Regulation of cerebral blood flow.

Authors:  Eric C Peterson; Zhengfeng Wang; Gavin Britz
Journal:  Int J Vasc Med       Date:  2011-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.